Type I interferons and limitin: A comparison of structures, receptors, and functions

Cytokine and Growth Factor Reviews

Volumn 12, Issue 4, 2001, Pages 337-348

  Oritani, Kenji ^a   Kincade, Paul W ^b   Zhang, Cai ^b   Tomiyama, Yoshiaki ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Antitumor; Immune defence; Interferon; Limitin; Myelosuppression

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; CYTOKINE; CYTOKINE RECEPTOR; INTERFERON; INTERFERON RECEPTOR; LIMITIN; OMEGA INTERFERON; TAU INTERFERON; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ANIMAL; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BONE MARROW SUPPRESSION; CHEMISTRY; COMPARATIVE STUDY; ERYTHROID PRECURSOR CELL; HUMAN; IMMUNITY; IMMUNOMODULATION; MITOSIS INHIBITION; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMYELOCYTE; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING;

AMINO ACID SEQUENCE; ANIMALS; CYTOKINES; HUMANS; INTERFERON TYPE I; MOLECULAR SEQUENCE DATA;

EID: 0034855236     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(01)00009-0     Document Type: Review

References (104)

1. Virus interference: The interferon
2. Type I interferon
3. Review of recent developments in the molecular characterization of recombinant alpha interferons on the 40th anniversary of the discovery of interferon
4. Biological properties of recombinant α-interferons: 40th Anniversary of the discovery of interferons
5. Interferons and their actions
6. Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors
7. Structure of the type I interferon gene cluster determined from YAC clone contig
8. Linkage analysis of the murine interferon-a locus on chromosome 4
9. A novel class of human type I interferons
10. Genes for the trophoblast interferons in sheep, goat, and musk ox and distribution of related genes among mammals
11. Unique features of the trophoblast interferons
12. Limitin: An interferonlike cytokine without myelo-erythroid suppressive properties
13. Interferon induction by viruses
14. Tumor necrosis factor acts synergistically with autocrine interferon-β mRNA levels in human fibroblasts
15. Differential expression of human interferon genes
16. Regulation of IFN-α/β genes: Evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-α/β
17. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3)
18. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1
19. The genes for the trophoblast interferons and the related interferon-α II possess distinct 5′-promoter and 3′-flanking sequences
20. Interferon from 1981 to 1986
21. Functional role of type I and type II interferons in antiviral defense
22. Interferon action: Binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated Hela cells infected with encephalomyocarditis virus
23. Biochemistry of interferons and their actions
24. Mechanisms of interferon action
25. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein
26. Enhanced virus resistance of transgenic mice expressing the human MxA protein
27. Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon
28. Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes
29. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase
30. Constitutive expression of a 2′, 5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression
31. Resident bone marrow macrophages produce type I interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells
32. Indirect suppression of IL-7-responsive B cell precursors by vasoactive intestinal peptide
33. Early murine B lymphocyte precursors are directly responsive to negative regulators
34. Specific depletion of the pre B-cell population induced by abberant expression of human interferon regulatory factor 1 gene in transgenic mice
35. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development
36. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen activated T lymphocytes
37. Stimulation of naive and memory T cells by cytokines
38. Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes
39. The effect of interferon treatment of targets on susceptibility to cytotoxic T-lymphocyte killing: Augmentation of allogenic killing: Augmentation of allogenic killing and virus specific killing relative to viral antigen expression
40. Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells
41. Interferonalpha (IFN-α) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway
42. Endogenous interferon alpha/beta produced by Kupffer cells inhibits interleukin-1, tumor necrosis factor-a production and interleukin-2-induced activation of nonparenchymal liver cells
43. Interferons as inhibitors of interleukin 1-induced interleukin I synthesis
44. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by NF-kB site
45. Requirement for transcription factor IRF-1 in NO synthetase induction in macrophages
46. Viruses and bone marrow failure
47. Virus-induced transient bone marrow aplasia: Major role of interferona/b during acute infection with the noncytopathic lymphocytic choriomeningitis virus
48. Impairment of T and B cell development by treatment with type I interferon
49. Gamma interferon (IFNγ) and IFNα/β suppress murine myeloid colony formation (CFU-C): Magnitude of suppression is dependent upon level of colony-stimulating factor (CSF)
50. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells
51. Alpha-interferon: Differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hematopoietic progenitor cells
52. Downregulation of interleukin 8 gene expression in human fibroblasts: Mechanism of transcriptional inhibition by interferon
53. Regulation of cytokine expression by interpheron alpha in human bone marrow stromal cells: Inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist
54. Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells
55. Stromal cell lines which support lymphocyte growth. II. Characteristics of a suppressive subclone
56. Both Stat3-activation and Stat3-independent BCL2 downregulation are important for interleukin-6-induced apoptosis of IA9-M cells
57. Structure and expression of cloned murine IFN-alpha genes
58. Structure and expression of a cloned cDNA for mouse interferon-beta
59. The type-I interferon receptor. The long and short of it
60. Direct binding to and tyrosine phosphorylation of the a subunit of the type I interferon receptor by p135tyk2 tyrosine kinase
61. The human interferon alpha/beta receptor: Characterization and molecular cloning
62. Interferons α/β and their receptors: Place in the hierarchy of cytokines
63. Anti-rhinoviral activity of recombinant and hybrid species of interferon alpha
64. Different relative activities of human cell derived interferon alpha subtypes: IFN alpha 8 has very high antiviral potency
65. Characterization of beta R1, a gene that is selectively induced by interferon-beta (IFN-β) compared with IFN-α
66. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and an associated surface protein in response to IFN alpha and IFN beta
67. The sequence 130-137 of human interferon-α2 is involved in the competition of interferon, prothymosin and cholera toxin B subunit for common receptors on human fibroblasts
68. Cholera toxin genes: Nucleotide sequence, deletion analysis and vaccine development
69. Specificity and reversibility of interferon ganglioside interaction
70. Cholera toxin inhibits interferon action
71. Evidence for glycosphingolipid modification of the type I interferon receptor
72. Three dimensional crystal structure of recombinant murine interferon-β
73. Zinc mediated dimer of human interferon-α2b revealed by X-ray crystallography
74. Possible conformation of interferons: A prediction based on amino acid composition and sequence
75. Theoretical conformational analysis of a family of a helical immunocytokines
76. Different functional sites on rIFN-alpha 2 and their relation to the cellular binding site
77. Mapping of two immunodominant structures on human interferon alpha 2c and their role in binding to cells
78. α and β interferons and their receptor and their friends and relations
79. A three-dimensional model of interferon-tau
80. Signal transduction in the interferon system
81. Interferon response pathway-a paradigm for cytokine signaling
82. Interferon alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3' kinase
83. The type I interferon receptor mediates tyrosine phophorylation of insulin receptor substrate 2
84. Requirement for MAP kinase activity in interferon alpha and beta stimulated gene expression through STAT proteins
85. Antiproliferative action of interferon alpha requires components of T-cell-receptor signalling
86. β transforming growth factors are potential regulators of B lymphopoiesis
87. IL-1 inhibits B cell differentiation in long term bone marrow cultures
88. Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1a
89. Interleukin 4 (B cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hematopoietic progenitor cells
90. IL-10 inhibits IL-7-mediated murine pre-B cell growth in vitro
91. Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors
92. Interferon arrests proliferation and causes apoptosis in stromal cell/interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulin-positive B cells
93. Suppression of B lymphopoiesis during normal pregnancy
94. Pregnancy related steroids are potential negative regulators of B lymphopoiesis
95. Cell interaction molecules utilized in bone marrow
96. Lymphopoiesis and matrix glycoprotein SC1/ECM2
97. Regulatory mechanisms in stem cell biology
98. B cell development and differentiation
99. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease
100. The interferons
101. Safety profile of interferon-a therapy
102. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C
103. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-β therapy
104. Mutations in the nonstructural 5A gene of european hepatitis C isolates and response to interferon alpha